Home » Topics » Regulatory » Patents

Patents
RSS

Novel oncolytic agents reported in patent literature

Aug. 4, 2008

Novel NS5B polymerase inhibitors described in recent patents

Aug. 4, 2008

New agents intended for use in treatment of anxiety, depression, etc., disclosed in recent patents

Aug. 1, 2008

Novel anticancer agents disclosed in recent patent literature

Aug. 1, 2008

Recent patents describe novel therapeutic agents for asthma and other respiratory disorders

Aug. 1, 2008

New agents for diagnosis of congestive heart failure described in BMS patent

July 31, 2008

Bristol-Myers Squibb prepares and tests novel factor VIIa inhibitors

July 31, 2008

Novel antiinfective agents reported in recent patents

July 31, 2008

Novel Rho kinase inhibitors developed at sanofi-aventis

July 30, 2008

Advances in development of agents for neurological disorders documented in recent patents

July 30, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...